JP2024534952A5 - - Google Patents

Info

Publication number
JP2024534952A5
JP2024534952A5 JP2024515109A JP2024515109A JP2024534952A5 JP 2024534952 A5 JP2024534952 A5 JP 2024534952A5 JP 2024515109 A JP2024515109 A JP 2024515109A JP 2024515109 A JP2024515109 A JP 2024515109A JP 2024534952 A5 JP2024534952 A5 JP 2024534952A5
Authority
JP
Japan
Prior art keywords
extract
fucus
composition according
acid
chebula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024515109A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024534952A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/042799 external-priority patent/WO2023038999A1/en
Publication of JP2024534952A publication Critical patent/JP2024534952A/ja
Publication of JP2024534952A5 publication Critical patent/JP2024534952A5/ja
Pending legal-status Critical Current

Links

JP2024515109A 2021-09-07 2022-09-07 卵巣老化、卵巣疾患および状態、ならびにその症状を処置するための組成物および方法 Pending JP2024534952A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163241429P 2021-09-07 2021-09-07
US63/241,429 2021-09-07
PCT/US2022/042799 WO2023038999A1 (en) 2021-09-07 2022-09-07 Compositions and methods for treating ovarian aging, ovarian diseases and conditions, and symptoms thereof

Publications (2)

Publication Number Publication Date
JP2024534952A JP2024534952A (ja) 2024-09-26
JP2024534952A5 true JP2024534952A5 (https=) 2026-04-24

Family

ID=85506938

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024515109A Pending JP2024534952A (ja) 2021-09-07 2022-09-07 卵巣老化、卵巣疾患および状態、ならびにその症状を処置するための組成物および方法

Country Status (4)

Country Link
US (1) US20250017992A1 (https=)
EP (1) EP4398921A4 (https=)
JP (1) JP2024534952A (https=)
WO (1) WO2023038999A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116798634B (zh) * 2023-08-25 2023-11-21 北京大学深圳医院 一种fsh启动剂量预测系统、电子设备及存储介质
CN119112879A (zh) * 2024-09-26 2024-12-13 郑州大学第一附属医院 尿石素a在制备延缓卵巢衰老药物或保健食品中的应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU782286B2 (en) * 1999-06-30 2005-07-14 Advanced Cell Technology, Inc. Cytoplasmic transfer to de-differentiate recipient cells
US7776915B2 (en) * 2005-03-24 2010-08-17 Tracie Martyn International, Llc Topical formulations and methods of use
US20070027107A1 (en) * 2005-07-29 2007-02-01 Curt Hendrix Compositions and methods for treating estrogen-dependent diseases and conditions
US20070065396A1 (en) * 2005-09-21 2007-03-22 Tracie Martyn International, Llc Topical macqui berry formulation
US8212076B2 (en) * 2006-08-04 2012-07-03 Covalence, Inc. Prevention of cellular senescence in mammals by natural peptide complexes
WO2009066712A1 (ja) * 2007-11-21 2009-05-28 Kracie Pharma, Ltd. アロマターゼ阻害剤
US10967019B2 (en) * 2015-11-30 2021-04-06 Taiwan Mitochondrion Applied Technology Co., Ltd. Method for protecting mitochondria in retina cell
TWI728079B (zh) * 2017-03-24 2021-05-21 台灣粒線體應用技術股份有限公司 餘甘子萃取物用於製備提升粒線體功能以對抗老化之組合物的用途
US20200054682A1 (en) * 2018-08-14 2020-02-20 Imel Biotherapeutics, Inc. Methods and compositions for treating mitochondrial disease or disorders and heteroplasmy

Similar Documents

Publication Publication Date Title
KR100402563B1 (ko) 에스트로겐에 민감한 질병을 치료하기 위한 조성물 및 방법
Biswas et al. The role of nitric oxide in the process of implantation in rats
KR102276326B1 (ko) 피부 회춘을 위한 펩타이드 및 이것을 사용하는 방법
Weingart et al. The role of minocycline in the treatment of intracranial 9L glioma
KR101791828B1 (ko) 탈모증 치료용 비타민 ｄ3 및 이의 유사체들
JP2024534952A5 (https=)
US9782426B2 (en) Anti-viral therapeutic composition
WO2001092289A1 (en) SKIN TISSUE REGENERATION PROMOTERS COMPRISING GINSENOSIDE Rb1
JP4008192B2 (ja) ジンセノサイドＲｂ１からなる皮膚組織再生促進剤
AU6489300A (en) Use of rhamnolipids in wound healing, treatment and prevention of gum disease and periodontal regeneration
Russo et al. Hormonally induced differentiation: a novel approach to breast cancer prevention
JP2020023563A (ja) ビタミンｄを使用する化学療法誘発性脱毛症の予防又は軽減
RU2414215C1 (ru) Средство для улучшения и/или восстановления репродуктивной функции
Benagiano et al. Fibroids: overview of current and future treatment options
EP2994144B1 (en) Topical preparations comprising hyaluronic acid, verbascoside and glycerophosphoinositol
CN101822643A (zh) 川芎嗪纳米粒及其制备方法和制药中的应用
EA001308B1 (ru) Средство, обладающее противовоспалительным, антисептическим и регенераторным действием
MXPA04005771A (es) Composicion de estrogeno y de otras hormonas con ascorbato, lisina, prolina y otras substancias.
RU2168996C1 (ru) Стабильный раствор ретинола пальмитата и способ лечения заболеваний кожи
Parsanezhad et al. Medical management of uterine fibroids
RU2646453C1 (ru) Способ лечения атрофического вагинита
JP7668046B2 (ja) 毛包幹細胞の活性化用組成物、並びに毛包幹細胞におけるｗｎｔ３遺伝子の発現抑制用組成物及び毛包幹細胞におけるｂｍｐ４遺伝子の発現抑制用組成物
Laschke et al. Genistein does not affect vascularization and blood perfusion of endometriotic lesions and ovarian follicles in dorsal skinfold chambers of Syrian golden hamsters
Koike et al. Successful Treatment of Unscheduled Uterine Bleeding During Transdermal Menopausal Hormone Therapy Combined With Bazedoxifene
CN119326768A (zh) 包含贝美前列素的组合物及其用途